These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 27904861)

  • 21. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
    Han K; Kim JH
    World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?
    Meza-Junco J; Montano-Loza AJ; Liu DM; Sawyer MB; Bain VG; Ma M; Owen R
    Cancer Treat Rev; 2012 Feb; 38(1):54-62. PubMed ID: 21726960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New Insights on Liver-Directed Therapies in Hepatocellular Carcinoma.
    Dalzell CG; Taylor AC; White SB
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of interventional radiology in the management of hepatocellular carcinoma.
    Molla N; AlMenieir N; Simoneau E; Aljiffry M; Valenti D; Metrakos P; Boucher LM; Hassanain M
    Curr Oncol; 2014 Jun; 21(3):e480-92. PubMed ID: 24940108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Transarterial ablative therapy of hepatocellular carcinoma].
    Mahnken AH
    Radiologe; 2014 Jul; 54(7):685-93. PubMed ID: 25047524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical management of hepatocellular carcinoma.
    Pang TC; Lam VW
    World J Hepatol; 2015 Feb; 7(2):245-52. PubMed ID: 25729479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma.
    Saviano A; Iezzi R; Giuliante F; Salvatore L; Mele C; Posa A; Ardito F; De Gaetano AM; Pompili M;
    J Vasc Interv Radiol; 2017 Nov; 28(11):1512-1519. PubMed ID: 28734848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the treatment response of HCC.
    Kim KW; Lee JM; Choi BI
    Abdom Imaging; 2011 Jun; 36(3):300-14. PubMed ID: 21279353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimally invasive image-guided therapies for hepatocellular carcinoma.
    Abdelsalam ME; Murthy R; Avritscher R; Mahvash A; Wallace MJ; Kaseb AO; Odisio BC
    J Hepatocell Carcinoma; 2016; 3():55-61. PubMed ID: 27785450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local Therapies for Hepatocellular Carcinoma and Role of MRI-Guided Adaptive Radiation Therapy.
    Liu Y; Chou B; Yalamanchili A; Lim SN; Dawson LA; Thomas TO
    J Clin Med; 2023 May; 12(10):. PubMed ID: 37240623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermediate hepatocellular carcinoma: How to choose the best treatment modality?
    Di Costanzo GG; Tortora R
    World J Hepatol; 2015 May; 7(9):1184-91. PubMed ID: 26019734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work review.
    Osaki Y; Nishikawa H
    Hepatol Res; 2015 Jan; 45(1):59-74. PubMed ID: 24965914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microwave Ablation in the Liver: An Update.
    Hartley-Blossom Z; Alam M; Stone J; Iannuccilli J
    Surg Technol Int; 2020 Nov; 37():72-78. PubMed ID: 32681731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver-directed therapy for hepatocellular carcinoma.
    Narsinh KH; Duncan DP; Newton IG; Minocha J; Rose SC
    Abdom Radiol (NY); 2018 Jan; 43(1):203-217. PubMed ID: 29230556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality.
    Kim DY; Han KH
    Hepatol Int; 2016 Nov; 10(6):883-892. PubMed ID: 27126821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Goals and targets for personalized therapy for HCC.
    Couri T; Pillai A
    Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular Carcinoma: Current Concepts in Diagnosis, Staging and Treatment.
    Schütte K; Schulz C; Malfertheiner P
    Gastrointest Tumors; 2014 Jun; 1(2):84-92. PubMed ID: 26672483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Image-guided therapies in the treatment of hepatocellular carcinoma: A multidisciplinary perspective.
    Willatt J; Hannawa KK; Ruma JA; Frankel TL; Owen D; Barman PM
    World J Hepatol; 2015 Feb; 7(2):235-44. PubMed ID: 25729478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence-based diagnosis and locoregional therapy for hepatocellular carcinoma.
    Pleguezuelo M; Germani G; Marelli L; Xiruochakis E; Misseri M; Manousou P; Arvaniti V; Burroughs AK
    Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):761-84. PubMed ID: 19090737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
    Eggert T; Greten TF
    Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.